Finance & valuation

Latest content

New 4G/5G landscape shows which SEP owners have strongest global coverage

Tech+IP Capital report proposes new methodology for looking at patent portfolio geography, finding Qualcomm’s 4G holdings have unmatched reach

02 June 2022

BlackBerry's $600 million patent sale hits trouble

Company now exploring other options after proposed buyer fails to secure financing by the end of May deadline

01 June 2022

IPBC Global 2022 approaches sell-out territory

The world’s pre-eminent event focusing on IP value creation takes place in Chicago from 12 to 14 June with over 500 senior delegates set to attend

19 May 2022

Report questions high published royalty rates for voice codec SEPs

Analysis from Stout suggests rates sought by certain Enhanced Voice Services (EVS) patent owners are out of line with the overall 3G/4G/5G FRAND landscape

18 May 2022

Stealthy biotech buys up patent portfolios in string of recent deals

Terran Biosciences has emerged from obscurity to snap up slew of IP rights in the past two months

04 May 2022

Delaware Judge’s litigation finance disclosure may harm plaintiffs, lead to defence settlements

Patent litigators who represent plaintiffs and defendants agree the new standing order favours the defence, but one litigation financier predicts well-financed patentees backed by reputable lenders will get the upper hand

29 April 2022

Dealing with 5G disappointment

The latest wireless standard hasn’t yet found its ‘killer app’ for consumers, and it’s affecting licensing negotiations

23 April 2022

New customer on the secondary patent market: litigation finance companies

Patent brokers and litigation financiers say that over the past year there is a growing trend of lawsuit funders exploring the idea of acquiring their own patent portfolios for monetisation through licensing or litigation

20 April 2022

The advantages of using hedonic regression to measure the value of standardised technologies

Hedonic regression is a dependable and impartial way to estimate the value of a standardised technology. Further, it can be applied to a range of products, especially those with multiple features.

13 April 2022

CRISPR FTO complexities not going anywhere in wake of Broad Institute victory, says IP chief on the CVC side

Following major US CRISPR decision, Michael Arciero, VP of IP at ERS Genomics, tells IAM that tricky patent landscapes are the new normal in biotech

04 April 2022

Unlock unlimited access to all IAM content